SHOCKING: 10 | Mind Blowing Facts

Makhana or Roasted Chana: Which Is Better for Weight Loss

Increased knowledge about the harm that can be done by junk foods, Indians have resorted to more traditional healthful snacking. Two such healthy snacks include makhana) and roasted chana both tasty and nutritious. The health that continues to be popular among rural and semi-urban Indians due to its lower price…

MyLifeXP · Jul 30

GLP-1 Drugs Did Not Lower Relapse Risk in Crohn's and Colitis Patients, a Large Claims Analysis Found

A claims study found GLP-1 drugs did not reduce IBD relapse in patients with obesity or diabetes, and did not raise safety events.

Medical Daily · Jul 29

One Prediabetes Subgroup Kept Sliding Toward Diabetes Despite Years of Sustained Weight Loss

One prediabetes subgroup kept progressing toward diabetes despite sustained 8% weight loss and the steepest drop in insulin secretion.

Medical Daily · Jul 29

A woman new to United Healthcare is surprised when a prescription to battle pre-diabetes is denied. Then they allegedly sent her a bathroom scale

They did note that the scale was “really nice.”

We Got This Covered · Jul 27

Patients Paid Less for GLP-1s While Total Spending Climbed, and Formularies Have Been Swinging Ever Since

A study found GLP-1 out-of-pocket costs fell as total spending rose. Here is what formulary swings mean for your coverage at renewal.

Medical Daily · Jul 27

Ozempic Side Effects: What New Research Reveals About the Risks and What Happens When You Stop

Ozempic aids in weight loss and diabetes management but raises concerns about side effects and weight regain post-treatment, highlighting the need for informed decision-making and long-term management strategies.

International Business Times UK · Jul 27

Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk

A new BMJ study links Ozempic and Mounjaro to 37–68% higher hair loss risk. The FDA is evaluating a safety signal. What patients need to know before their next dose.

Medical Daily · Jul 25

Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads

Novo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers about treatment comparisons. Lilly denies wrongdoing and stands by its advertising claims. Both companies compete in the growing obesity and diabetes drug market. Novo Nordisk argues Lilly uses outdated…

The Economic Times · Jul 24

Millions of family caregivers manage complex diets for older relatives – often with little nutritional guidance

My first science experiment was in sixth grade for our county’s science fair. Over three months, I tested how my grandfather’s blood sugar responded to green leafy vegetables versus brown rice at dinnertime. My mom would prepare traditional South Indian meals, including those foods, and my dad would supervise as…

The Conversation · Jul 24

Australian regulator warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic

TGA says product information for some diabetes and weight loss drugs updated with warning of NAION disorder

The Guardian - AU · Jul 24